Protective effect of exogenous phospholipid on aspirin-induced gastric mucosal injury
- PMID: 3799892
- DOI: 10.1016/0002-9610(87)90200-5
Protective effect of exogenous phospholipid on aspirin-induced gastric mucosal injury
Abstract
The protective effects of exogenous phospholipid on aspirin-induced gastric mucosal injury were examined in a canine chamber model which provided two separate segments of mucosa supplied by a single vascular pedicle. In each dog, one segment was treated with a suspension of surface-active phospholipid, similar in composition to that normally present in the gastric mucosa, whereas the other segment served as the control. Pretreatment of the test segments significantly prevented aspirin-induced disruption of the mucosal barrier as evidenced by an increase in potential difference and a decrease in acid back-diffusion and sodium ion and potassium ion flux. These findings were associated with a marked reduction in the degree of mucosal injury. Our results support the recent hypothesis that surface-active phospholipid plays an important role in gastric mucosal defense against the damaging effects to luminal acid.
Similar articles
-
Secretory state of gastric mucosa and its resistance to aspirin injury.Am J Surg. 1978 Jan;135(1):115-9. doi: 10.1016/0002-9610(78)90020-x. Am J Surg. 1978. PMID: 23692
-
Protective effect of acetaminophen against aspirin- and ethanol-induced damage to the human gastric mucosa.Gastroenterology. 1984 Apr;86(4):728-33. Gastroenterology. 1984. PMID: 6698373 Clinical Trial.
-
Relationship between lesion formation and permeability of rat gastric mucosa to H+ and other cations.Br J Pharmacol. 1982 Feb;75(2):325-31. doi: 10.1111/j.1476-5381.1982.tb08790.x. Br J Pharmacol. 1982. PMID: 6964662 Free PMC article.
-
Gastric acid secretion and mucosal defense mechanisms with special reference to the role of cimetidine in critically ill patients.Clin Ther. 1986;8 Suppl A:2-13. Clin Ther. 1986. PMID: 3539348 Review.
-
How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?Clin Invest Med. 1987 May;10(3):251-8. Clin Invest Med. 1987. PMID: 3304754 Review.
Cited by
-
Gastric mucosal barrier: barrier to hydrogen ions imparted by gastric surfactant in vitro.Gut. 1992 Aug;33(8):1039-41. doi: 10.1136/gut.33.8.1039. Gut. 1992. PMID: 1398228 Free PMC article.
-
Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection?World J Gastroenterol. 2001 Apr;7(2):149-51. doi: 10.3748/wjg.v7.i2.149. World J Gastroenterol. 2001. PMID: 11819753 Free PMC article. No abstract available.
-
Dietary Phytosterols Protective Against Peptic Ulceration.Gastroenterology Res. 2011 Aug;4(4):149-156. doi: 10.4021/gr328w. Epub 2011 Jul 20. Gastroenterology Res. 2011. PMID: 27942332 Free PMC article.
-
Gastric surfactant and the hydrophobic mucosal barrier.Gut. 1996 Nov;39(5):621-4. doi: 10.1136/gut.39.5.621. Gut. 1996. PMID: 9026472 Free PMC article. No abstract available.
-
Effects of 16,16-dimethyl prostaglandin E2 on glycoprotein and lipid synthesis of gastric epithelial cells grown in a primary culture.In Vitro Cell Dev Biol. 1991 Jan;27(1):39-46. doi: 10.1007/BF02630893. In Vitro Cell Dev Biol. 1991. PMID: 2013552
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources